Fast, automated AST Avails Medical specializes in rapid, automated antibiotic susceptibility testing with the eQUANT platform, offering significant workflow time reductions from positive blood cultures. This presents an opportunity to target hospital labs seeking faster time-to-result for bloodstream infections.

FDA cleared edge The eQUANT system is FDA 510(k) cleared, providing a regulatory-backed product with smoother procurement for clinical laboratories in hospital systems and central laboratories, reducing perceived risk for adoption.

Broad lab applicability The platform is designed to fit within existing workflows and budgets across community hospitals to large academic centers, suggesting a broad target base and scalable adoption across multi-site health networks.

Expansion opportunities In development: RUO eQUANT and eAST platforms aim to broaden capabilities to non-AST downstream applications (e.g., MALDI-TOF ID) and direct-from-PBC testing, offering upsell paths to current customers and potential cross-sell with adjacent microbiology workflows.

Leadership and growth Recent leadership hires in finance, marketing, sales, and commercial operations indicate a commercial scale-up and investment in go-to-market capabilities, signaling readiness for enterprise sales outreach and strategic partnerships.